Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_1
2
33%
Ph phase_3
1
17%
Ph not_applicable
3
50%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Other(1)

Detailed Status

Completed5
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (33.3%)
Phase 31 (16.7%)
N/A3 (50.0%)

Trials by Status

completed583%
unknown117%

Recent Activity

0 active trials
Showing 5 of 6
completednot_applicable

Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment

NCT05152004
completednot_applicable

Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy

NCT03383003
completednot_applicable

Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication

NCT02596620
unknownphase_3

Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections

NCT02186145
completedphase_1

Bioavailability Study of Metronidazole Capsules Under Fed Conditions

NCT01380522
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05152004Not Applicable

Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment

Completed
NCT03383003Not Applicable

Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy

Completed
NCT02596620Not Applicable

Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication

Completed
NCT02186145Phase 3

Efficacy and Safety Study of Metronidazole, Nystatin and Dexamethasone Combination Therapy in Bacterial and Fungal Vaginal Infections

Unknown
NCT01380522Phase 1

Bioavailability Study of Metronidazole Capsules Under Fed Conditions

Completed
NCT01380509Phase 1

Bioavailability Study of Metronidazole Capsules Under Fasting Conditions

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6